DRIO
DarioHealth Corp
6.30$
-4.8%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +64.8% | -23.7% | +79.7% | +102.5% | +74.4% | +44.1% | +184.6% | +18.3% | -19.1% | +23.3% | -7.4% | |
| – | +108.5% | -31.5% | +105.9% | +120.2% | +72.1% | +48.9% | +33.6% | +43.7% | -27.8% | -14.4% | -14.1% | |
| – | +83.8% | -59.1% | +240.2% | +195.8% | +87.2% | +38.9% | +25.9% | +37.1% | -25.4% | -24.5% | -5.5% | |
| – | +79.1% | -52.1% | +201.7% | +176.6% | +87.2% | +38.9% | +25.9% | +37.1% | -25.4% | -22.7% | -7.8% | |
| – | -33.3% | +1,218.2% | +50.0% | -46.2% | +204.3% | +139.3% | +4.8% | +259.2% | -43.2% | +46.9% | -50.1% | |
| – | +156.8% | +47.8% | +33.3% | +16.3% | +2.7% | +62.2% | +171.6% | +27.7% | -36.4% | -6.1% | -9.2% | |
| – | -23.4% | +20.3% | -3.6% | -15.7% | +92.8% | -59.2% | +21.9% | +12.3% | – | – | – | |
| – | – | – | – | – | – | – | – | +0.0% | +0.0% | +37.9% | +0.0% | |
| – | – | – | – | – | – | – | – | -20.4% | -45.5% | +247.2% | -15.1% | |
| – | -23.5% | +142.2% | -71.0% | +71.2% | +9.9% | +27.9% | +109.8% | +157.5% | -2.4% | +22.5% | -10.1% | |
| – | +4.6% | +73.1% | +3.1% | +71.3% | +1.1% | +34.8% | +104.4% | +34.6% | -35.4% | +33.2% | -44.0% | |
| – | – | – | – | – | – | -2.2% | -14.2% | +3,327.1% | -55.4% | +46.5% | -92.8% | |
| – | +38.1% | +85.3% | +2.2% | +39.0% | -35.7% | +49.8% | +106.0% | -54.6% | -51.3% | +169.2% | -3.8% | |
| – | – | – | – | – | – | – | – | – | +35.8% | -4.6% | +31.0% | |
| – | – | -941.8% | – | +126.5% | +111.7% | +49.0% | +203.9% | -6.5% | -27.3% | +23.9% | -5.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +293.6% | +174.2% | +85.1% | +143.2% | +93.6% | +163.1% | +178.2% | +42.5% | +20.0% | +42.5% | +22.8% |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.